These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
446 related items for PubMed ID: 9355837
1. Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells. Lehmann M, Graser E, Risch K, Hancock WW, Müller A, Kuttler B, Hahn HJ, Kupiec-Weglinski JW, Brock J, Volk HD. Transplantation; 1997 Oct 27; 64(8):1181-7. PubMed ID: 9355837 [Abstract] [Full Text] [Related]
2. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts. Binder J, Lehmann M, Graser E, Hancock WW, Watschinger B, Onodera K, Sayegh MH, Volk HD, Kupiec-Weglinski JW. Transplantation; 1996 Mar 15; 61(5):804-11. PubMed ID: 8607187 [Abstract] [Full Text] [Related]
5. Distinct tolerance pathways in sensitized allograft recipients after selective blockade of activation signal 1 or signal 2. Onodera K, Chandraker A, Volk HD, Ritter T, Lehmann M, Kato H, Sayegh MH, Kupiec-Weglinski JW. Transplantation; 1999 Jul 27; 68(2):288-93. PubMed ID: 10440403 [Abstract] [Full Text] [Related]
6. Thymus-dependent, anti-CD4-induced tolerance to rat cardiac allografts. Jaques BC, Ahmiedat H, Alastair Gracie J, Marshall HE, Middleton SE, Bolton EM, Bradley JA. Transplantation; 1998 Nov 27; 66(10):1291-9. PubMed ID: 9846511 [Abstract] [Full Text] [Related]
7. Induction of specific tolerance to allografts in rats by therapy with non-mitogenic, non-depleting anti-CD3 monoclonal antibody: association with TH2 cytokines not anergy. Plain KM, Chen J, Merten S, He XY, Hall BM. Transplantation; 1999 Feb 27; 67(4):605-13. PubMed ID: 10071035 [Abstract] [Full Text] [Related]
8. Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients. Onodera K, Hancock WW, Graser E, Lehmann M, Sayegh MH, Strom TB, Volk HD, Kupiec-Weglinski JW. J Immunol; 1997 Feb 15; 158(4):1572-81. PubMed ID: 9029092 [Abstract] [Full Text] [Related]
9. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. Sayegh MH, Akalin E, Hancock WW, Russell ME, Carpenter CB, Linsley PS, Turka LA. J Exp Med; 1995 May 01; 181(5):1869-74. PubMed ID: 7536798 [Abstract] [Full Text] [Related]
10. Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4. Hall BM, Fava L, Chen J, Plain KM, Boyd RA, Spicer ST, Berger MF. J Immunol; 1998 Nov 15; 161(10):5147-56. PubMed ID: 9820484 [Abstract] [Full Text] [Related]
11. Tolerance to heart and kidney grafts induced by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) versus depleting anti-CD4 monoclonal antibody (OX-38) with donor antigen administration. Motoyama K, Arima T, Lehmann M, Flye MW. Surgery; 1997 Aug 15; 122(2):213-9; discussion 219-20. PubMed ID: 9288125 [Abstract] [Full Text] [Related]
13. Coexistence of Th1- and Th2-type cytokine profiles in anti-CD2 monoclonal antibody-induced tolerance. Krieger NR, Most D, Bromberg JS, Holm B, Huie P, Sibley RK, Dafoe DC, Alfrey EJ. Transplantation; 1996 Nov 15; 62(9):1285-92. PubMed ID: 8932273 [Abstract] [Full Text] [Related]
14. Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients. Onodera K, Lehmann M, Akalin E, Volk HD, Sayegh MH, Kupiec-Weglinski JW. J Immunol; 1996 Sep 01; 157(5):1944-50. PubMed ID: 8757313 [Abstract] [Full Text] [Related]
15. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration. Motoyama K, Arima T, Yu S, Lehmann M, Flye MW. Transplantation; 2000 Jan 27; 69(2):285-93. PubMed ID: 10670640 [Abstract] [Full Text] [Related]
16. Donor-specific tolerance by perioperative intrathymic injection of bone marrow cells in the rat cardiac allograft model: use of FK506 can shorten the necessary duration of pretransplant intrathymic conditioning. Ito A, Ito T, Kamiike W, Moriguchi A, Ohkawa A, Uchikoshi F, Tanaka S, Nakata S, Matsuda H. Transplantation; 1997 Sep 15; 64(5):752-7. PubMed ID: 9311715 [Abstract] [Full Text] [Related]
17. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide. Chowdhury NC, Saborio DV, Garrovillo M, Chandraker A, Magee CC, Waaga AM, Sayegh MH, Jin MX, Oluwole SF. Transplantation; 1998 Oct 27; 66(8):1059-66. PubMed ID: 9808492 [Abstract] [Full Text] [Related]
18. Predominant expression of T helper 2 cytokines and altered expression of T helper 1 cytokines in long-term allograft survival induced by intrathymic immune modulation with donor class I major histocompatibility complex peptides. Shirwan H, Barwari L, Khan NS. Transplantation; 1998 Dec 27; 66(12):1802-9. PubMed ID: 9884279 [Abstract] [Full Text] [Related]
19. Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration. Plain KM, Boyd R, Verma ND, Robinson CM, Tran GT, Hodgkinson SJ, Hall BM. Transplantation; 2007 Mar 27; 83(6):764-73. PubMed ID: 17414711 [Abstract] [Full Text] [Related]
20. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides. Saborio DV, Chowdhury NC, Jin MX, Chandraker A, Sayegh MH, Oluwole SF. Cell Transplant; 1999 Mar 27; 8(4):375-81. PubMed ID: 10478717 [Abstract] [Full Text] [Related] Page: [Next] [New Search]